Search

Your search keyword '"van Akkooi, A."' showing total 26 results

Search Constraints

Start Over You searched for: Author "van Akkooi, A." Remove constraint Author: "van Akkooi, A." Journal value in health Remove constraint Journal: value in health
26 results on '"van Akkooi, A."'

Search Results

1. PCN501 VALUE FOR MONEY IN METASTATIC CUTANEOUS MELANOMA: DO BENEFITS OUTWEIGH THE COSTS OF NOVEL DRUGS?

2. PCN497 A NATIONWIDE COST OF ILLNESS STUDY OF METASTATIC CUTANEOUS MELANOMA IN THE NETHERLANDS

3. PCN497 A NATIONWIDE COST OF ILLNESS STUDY OF METASTATIC CUTANEOUS MELANOMA IN THE NETHERLANDS

4. PCN501 VALUE FOR MONEY IN METASTATIC CUTANEOUS MELANOMA: DO BENEFITS OUTWEIGH THE COSTS OF NOVEL DRUGS?

5. PCN220 - END-OF-LIFE CARE IN PATIENTS WITH METASTATIC CUTANEOUS MELANOMA IN THE NETHERLANDS

6. PCN220 - END-OF-LIFE CARE IN PATIENTS WITH METASTATIC CUTANEOUS MELANOMA IN THE NETHERLANDS

7. Healthcare Costs of Ipilimumab in Patients with Advanced Cutaneous Melanoma in Dutch Clinical Practice

8. Real-World Outcomes of Ipilimumab in Patients with Advanced Melanoma in The Netherlands

9. Informal Care and Productivity Losses are Important in Advanced Cutaneous Melanoma: Results of the Dutch Melanoma Treatment Registry

10. Real-World Outcomes of Novel Treatments in Patients with Advanced Melanoma in The Netherlands

11. Informal Care and Productivity Losses are Important in Advanced Cutaneous Melanoma: Results of the Dutch Melanoma Treatment Registry

12. Quality of Life in Advanced Melanoma: Results of The Dutch Melanoma Treatment Registry

13. External Validity at Stake in Mapping Non-Preference Based Disease Specific Measures to Generic Preference-Based Utility Values in Advanced Cutaneous Melanoma

14. Healthcare Resource Use Alongside Novel Treatments for Advanced Melanoma in the Netherlands

15. Real-World Outcomes of Ipilimumab in Patients with Advanced Melanoma in The Netherlands

16. Real-World Outcomes of Novel Treatments in Patients with Advanced Melanoma in The Netherlands

17. Healthcare Resource Use Alongside Novel Treatments for Advanced Melanoma in the Netherlands

18. External Validity at Stake in Mapping Non-Preference Based Disease Specific Measures to Generic Preference-Based Utility Values in Advanced Cutaneous Melanoma

19. Quality of Life in Advanced Melanoma: Results of The Dutch Melanoma Treatment Registry

20. PCN110 - Healthcare Costs of Ipilimumab in Patients with Advanced Cutaneous Melanoma in Dutch Clinical Practice

22. PCN207 - Informal Care and Productivity Losses are Important in Advanced Cutaneous Melanoma: Results of the Dutch Melanoma Treatment Registry

23. PCN186 - Healthcare Resource Use Alongside Novel Treatments for Advanced Melanoma in the Netherlands

24. PCN8 - Real-World Outcomes of Novel Treatments in Patients with Advanced Melanoma in The Netherlands

26. PRM148 - External Validity at Stake in Mapping Non-Preference Based Disease Specific Measures to Generic Preference-Based Utility Values in Advanced Cutaneous Melanoma

Catalog

Books, media, physical & digital resources